Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Community-acquired pneumonia medication

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 1) P. aeruginosa infection is not suspected

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 2) Suspected P. aeruginosa infection

Major advances in managing community-acquired pneumonia – Corticosteroids

Major advances in managing community-acquired pneumonia – Antibiotics – dual vs single

Successful Treatment of Legionnaires’ Disease with Tigecycline in an Immunocompromised Man with a Legion of Antibiotic Allergies – Conclusions

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 5. Why are Diagnostics Important for LRTIs? (Antibiotic Stewardship)

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children – Conclusions

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review – On-going clinical trials

Successful Treatment of Legionnaires’ Disease with Tigecycline in an Immunocompromised Man with a Legion of Antibiotic Allergies – Discussion

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review – New antibiotics

Viral Infection Is Not Uncommon in Adult Patients with Severe Hospital-Acquired Pneumonia – Ethics Statement

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 3. How to Differentiate Bacterial from Viral LRTI at the Point of Care?

Characteristics of fever and response to antipyretic therapy in military personnel with adenovirus-positive community-acquired pneumonia – Comparison of clinicolaboratory findings between the Adv and non-Adv groups in patients who were unresponsive to initial antibiotics treatment

Viral Infection Is Not Uncommon in Adult Patients with Severe Hospital-Acquired Pneumonia – Study Setting

Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials – Conclusions

Characteristics of fever and response to antipyretic therapy in military personnel with adenovirus-positive community-acquired pneumonia – Comparison of treatment outcome

Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus – 2. Discussion

Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study – Pre-publication history

Respiratory virus of severe pneumonia in South Korea: Prevalence and clinical implications – Clinical impact of virus detection

How to approach and treat viral infections in ICU patients – Other therapies for treatment of influenza

How to approach and treat viral infections in ICU patients – Novel antivirals can be considered for treatment of respiratory viral infections

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial – Discussion

No Room for Error: Empiric Treatment for Fulminant Pneumonia – DISCUSSION

Pneumonia severity index in viral community acquired pneumonia in adults – Definitions

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults – Endpoints